Search research articles
Contact Us
Filters
Showing results (611-620 of 711) with videos related to
Page
of 72
Sort By:
Maryland Medical Journal (Baltimore, Md. : 1985)
|
November 1, 1985
Congenital cardiovascular malformations in the Baltimore-Washington area
J D Rubin, C Ferencz, R J McCarter, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
August 15, 2002
U.S. medical students' rotations in epidemiology and public health at state and local health departments
Andrew L Dannenberg, M Patricia Quinlisk, Ellen Alkon, et al.
Journal of Medicine
|
January 1, 1984
Hematologic disorders and congenital cardiovascular malformations: converging lines of research
C Ferencz, J D Rubin, R J McCarter, et al.
Journal of the American Geriatrics Society
|
May 14, 2025
Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA Trials
Lajjaben Patel, Matthew W Segar, Muhammad S Usman, et al.
Radiology
|
April 23, 2005
American College of Radiology clinical statement on noninvasive cardiac imaging
Jeffrey C Weinreb, Paul A Larson, Pamela K Woodard, et al.
Journal of Pediatric Orthopedics
|
February 8, 2013
A prospective comparison of computer-navigated and fluoroscopic-guided in situ fixation of slipped capital femoral epiphysis
Kenneth T Bono, Michael D Rubin, Kerwyn C Jones, et al.
Journal of the American College of Radiology : JACR
|
April 7, 2007
ACR clinical statement on noninvasive cardiac imaging
Jeffrey C Weinreb, Paul A Larson, Pamela K Woodard, et al.
Teratology
|
June 1, 1987
Cardiac and noncardiac malformations: observations in a population-based study
C Ferencz, J D Rubin, R J McCarter, et al.
Radiology
|
February 7, 2001
Aortic aneurysmal disease: assessment of stent-graft treatment-CT versus conventional angiography
M D Armerding, G D Rubin, C F Beaulieu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2009
Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens
K L Blackwell, M D Pegram, E Tan-Chiu, et al.
Page
of 72
Search research articles
Search
Showing results (611-620 of 711) with videos related to
Sort By:
Page
of 72
Maryland Medical Journal (Baltimore, Md. : 1985)
|
November 1, 1985
Congenital cardiovascular malformations in the Baltimore-Washington area
J D Rubin, C Ferencz, R J McCarter, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
August 15, 2002
U.S. medical students' rotations in epidemiology and public health at state and local health departments
Andrew L Dannenberg, M Patricia Quinlisk, Ellen Alkon, et al.
Journal of Medicine
|
January 1, 1984
Hematologic disorders and congenital cardiovascular malformations: converging lines of research
C Ferencz, J D Rubin, R J McCarter, et al.
Journal of the American Geriatrics Society
|
May 14, 2025
Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA Trials
Lajjaben Patel, Matthew W Segar, Muhammad S Usman, et al.
Radiology
|
April 23, 2005
American College of Radiology clinical statement on noninvasive cardiac imaging
Jeffrey C Weinreb, Paul A Larson, Pamela K Woodard, et al.
Journal of Pediatric Orthopedics
|
February 8, 2013
A prospective comparison of computer-navigated and fluoroscopic-guided in situ fixation of slipped capital femoral epiphysis
Kenneth T Bono, Michael D Rubin, Kerwyn C Jones, et al.
Journal of the American College of Radiology : JACR
|
April 7, 2007
ACR clinical statement on noninvasive cardiac imaging
Jeffrey C Weinreb, Paul A Larson, Pamela K Woodard, et al.
Teratology
|
June 1, 1987
Cardiac and noncardiac malformations: observations in a population-based study
C Ferencz, J D Rubin, R J McCarter, et al.
Radiology
|
February 7, 2001
Aortic aneurysmal disease: assessment of stent-graft treatment-CT versus conventional angiography
M D Armerding, G D Rubin, C F Beaulieu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2009
Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens
K L Blackwell, M D Pegram, E Tan-Chiu, et al.
Page
of 72